In contrast, as an another cis-target mRNA of LOC102160118, SLC25A15 is an OS- and metabolism-related gene serves as a biomarker for predicting adverse events in patients with stomach adenocarcinoma [31]. This evidence concerns the gene SLC25A15 and gastric adenocarcinoma.